+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tuberculosis Test Kit Market - Global Forecast 2026-2032- Product Image
Tuberculosis Test Kit Market - Global Forecast 2026-2032- Product Image
Sale

Tuberculosis Test Kit Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148911
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tuberculosis Test Kit Market is projected to reach USD 2.45 Billion in 2026. It is expected to continue growing at a CAGR of 5.93%, reaching USD 3.45 Billion by 2032.

Introduction to the Tuberculosis Test Kit Market

Tuberculosis test kits support the detection of active disease, latent infection, drug resistance, and treatment response. The market encompasses molecular assays, culture-based methods, smear microscopy, immunological tests, and related sample-collection and interpretation workflows. Demand is shaped by tuberculosis burden, public-health screening priorities, laboratory capacity, regulatory requirements, reimbursement, and the need for timely results in both centralized and decentralized settings.

Transformative Shifts Reshaping Tuberculosis Diagnosis

Tuberculosis diagnosis is shifting from reliance on conventional microscopy and culture alone toward integrated testing pathways that combine rapid molecular detection, resistance profiling, and clinical assessment. Portable instruments, cartridge-based workflows, improved sample preparation, and digital result reporting are helping extend diagnostic capability beyond major laboratories. At the same time, programs are placing greater emphasis on finding undiagnosed cases, screening high-risk populations, improving pediatric and extrapulmonary diagnosis, and linking test results to treatment initiation and surveillance systems.

How Artificial Intelligence Is Changing Tuberculosis Testing

Artificial intelligence is contributing most visibly to chest-imaging triage, quality assurance, workflow prioritization, and interpretation support. Automated radiography analysis can help identify individuals who warrant confirmatory testing, while algorithmic tools may assist laboratories with image review, anomaly detection, and operational monitoring. Effective deployment still depends on representative validation data, transparent performance assessment, clinical oversight, cybersecurity, interoperability, and clear regulatory accountability. AI is therefore best viewed as an augmentation layer within a diagnostic pathway rather than a replacement for microbiological confirmation.

Regional Insights: Access, Infrastructure, and Program Priorities

North America emphasizes screening among risk groups, antimicrobial resistance detection, laboratory quality, and integration with public-health reporting. Latin America continues to prioritize earlier case finding, decentralized access, and stronger links between primary care and reference laboratories. Europe is advancing coordinated surveillance, resistance testing, and standardized diagnostic pathways, while the Middle East is balancing migrant and vulnerable-population screening with uneven laboratory access. Africa remains focused on expanding testing coverage, specimen transport, HIV-associated tuberculosis diagnosis, and resistance surveillance. Asia-Pacific contains highly varied systems, combining advanced molecular capacity in some settings with major needs for affordable, scalable, and decentralized testing in high-burden areas.

Group Insights Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries are addressing cross-border transmission, urban screening, and uneven laboratory infrastructure through stronger referral networks and decentralized testing. BRICS members face diverse epidemiological and health-system conditions, making resistance detection, domestic manufacturing capability, and equitable access recurring priorities. The European Union is centered on harmonized standards, surveillance, and cross-border health coordination. G7 countries generally emphasize innovation, quality systems, targeted screening, and support for global tuberculosis control. GCC states focus on screening, occupational and migrant health, and rapid clearance pathways, while NATO members have an additional interest in continuity of diagnostic services during emergencies and in maintaining resilient medical supply chains.

Country Insights: Diverse Diagnostic Priorities

Australia emphasizes targeted screening, Indigenous health equity, and timely access across remote communities. Brazil prioritizes decentralized diagnosis, resistance testing, and integration with public-health services. Canada focuses on latent infection management, newcomer and Indigenous populations, and laboratory quality. China continues to emphasize broad case finding, molecular confirmation, and resistance surveillance. France, Germany, Italy, and Spain prioritize coordinated screening, clinical quality, and drug-resistance detection within European frameworks. India faces substantial needs for accessible molecular testing, specimen referral, and private-sector engagement. Japan and South Korea combine advanced laboratory capabilities with targeted screening and resistance monitoring. Mexico is strengthening early detection and regional access. Russia places emphasis on resistance testing and treatment-linked surveillance. The United Kingdom and United States focus on targeted screening, public-health reporting, vulnerable populations, and rapid confirmation.

Actions for Leaders: Build Integrated, Equitable Diagnostic Pathways

Industry leaders should design products around complete workflows rather than isolated assays, including specimen collection, transport, connectivity, quality control, and result interpretation. Priorities include improving performance with difficult specimens, simplifying operation in lower-resource settings, supporting resistance detection, and demonstrating usability in pediatric, extrapulmonary, and decentralized contexts. Partnerships with public-health programs and laboratories can clarify procurement and implementation requirements. Leaders should also establish evidence plans for AI-enabled tools, strengthen cybersecurity and interoperability, maintain resilient supply chains, and use transparent access strategies that support affordability without compromising quality.

Research Methodology for the Executive Summary

This summary uses a structured synthesis of the tuberculosis diagnostic landscape, focusing on test technologies, care pathways, public-health priorities, laboratory infrastructure, regulation, access, and implementation requirements. Findings are organized across the specified regions, country groups, and countries to capture differences in epidemiology, health-system maturity, screening practice, and resistance-management needs. The analysis excludes market estimates, market shares, forecasts, and company-specific claims, and treats artificial intelligence as a cross-cutting capability assessed through documented clinical, operational, and governance considerations.

Conclusion: Capability, Connectivity, and Equity Will Define Progress

The tuberculosis test kit market is being shaped by the need to detect disease earlier, identify resistance faster, and extend dependable testing to underserved populations. Molecular platforms, portable workflows, digital connectivity, and carefully validated AI can improve diagnostic pathways when supported by trained personnel, quality systems, specimen logistics, and treatment linkage. Progress will depend less on any single technology than on coordinated implementation that aligns clinical evidence, public-health priorities, regulatory expectations, affordability, and equitable access across diverse settings.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Tuberculosis Test Kit Market, by Product Type
7.1. Introduction
7.2. Culture Tests
7.3. Molecular Tests
7.4. Serological Tests
7.5. Skin Tests
8. Tuberculosis Test Kit Market, by Technology
8.1. Introduction
8.2. Culture Methods
8.3. Enzyme Immunoassay
8.4. Interferon Gamma Release Assays
8.5. Nucleic Acid Amplification Technology
8.5.1. Lamp Technology
8.5.2. Pcr Technology
9. Tuberculosis Test Kit Market, by Test Type
9.1. Introduction
9.2. Active Tuberculosis Tests
9.3. Latent Tuberculosis Tests
10. Tuberculosis Test Kit Market, by Application
10.1. Introduction
10.2. Diagnosis
10.3. Epidemiological Surveillance
10.4. Screening
10.5. Treatment Monitoring
11. Tuberculosis Test Kit Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Laboratories
11.4. Hospitals
11.5. Research Institutes
12. Tuberculosis Test Kit Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Tuberculosis Test Kit Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Tuberculosis Test Kit Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Becton, Dickinson and Company
16.3. bioMérieux SA
16.4. Cepheid, Inc.
16.5. Eiken Chemical Co., Ltd.
16.6. F. Hoffmann-La Roche AG (Roche Diagnostics)
16.7. Hain Lifescience GmbH
16.8. Hologic, Inc.
16.9. Molbio Diagnostics Private Limited
16.10. Oxford Immunotec Ltd.
16.11. QIAGEN N.V.
16.12. SD Biosensor, Inc.
16.13. Serum Institute of India Pvt. Ltd.
16.14. Siemens Healthineers AG
16.15. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Tuberculosis Test Kit Market, Years Considered for the Study
FIGURE 2. Global Tuberculosis Test Kit Market, Research Design
FIGURE 3. Global Tuberculosis Test Kit Market, Research Framework
FIGURE 4. Global Tuberculosis Test Kit Market, Data Triangulation
FIGURE 5. Global Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Tuberculosis Test Kit Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Tuberculosis Test Kit Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Tuberculosis Test Kit Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Tuberculosis Test Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Tuberculosis Test Kit Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 11. Global Tuberculosis Test Kit Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Tuberculosis Test Kit Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Tuberculosis Test Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Tuberculosis Test Kit Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Tuberculosis Test Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Tuberculosis Test Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Tuberculosis Test Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Tuberculosis Test Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Tuberculosis Test Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Tuberculosis Test Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Tuberculosis Test Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Tuberculosis Test Kit Market Segmentation & Coverage
TABLE 2. Global Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Culture Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Culture Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Culture Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Molecular Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Molecular Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Molecular Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Serological Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Serological Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Serological Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Skin Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Skin Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Skin Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 17. Global Culture Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Culture Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Culture Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Enzyme Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Enzyme Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Enzyme Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Interferon Gamma Release Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Interferon Gamma Release Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Interferon Gamma Release Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Nucleic Acid Amplification Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Nucleic Acid Amplification Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Nucleic Acid Amplification Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Lamp Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Lamp Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Lamp Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Pcr Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Pcr Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Pcr Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 36. Global Active Tuberculosis Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Active Tuberculosis Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Active Tuberculosis Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Latent Tuberculosis Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Latent Tuberculosis Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Latent Tuberculosis Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 43. Global Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Epidemiological Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Epidemiological Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Epidemiological Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Treatment Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Treatment Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Treatment Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 56. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. North America Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 78. North America Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 79. North America Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 80. North America Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 81. North America Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. North America Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Latin America Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Latin America Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. Latin America Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. Latin America Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 87. Latin America Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 88. Latin America Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Latin America Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Europe Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Europe Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 93. Europe Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 94. Europe Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 95. Europe Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Europe Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Middle East Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Middle East Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Middle East Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 100. Middle East Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 101. Middle East Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 102. Middle East Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Middle East Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Africa Tuberculosis Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Africa Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. Africa Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Africa Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 108. Africa Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 109. Africa Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Africa Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Global Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. ASEAN Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. ASEAN Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. ASEAN Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 115. ASEAN Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 116. ASEAN Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 117. ASEAN Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. ASEAN Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. GCC Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. GCC Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. GCC Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 122. GCC Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 123. GCC Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 124. GCC Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. GCC Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. European Union Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. European Union Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. European Union Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 130. European Union Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 131. European Union Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. European Union Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. BRICS Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. BRICS Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 137. BRICS Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 138. BRICS Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. BRICS Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. G7 Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. G7 Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. G7 Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. G7 Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 144. G7 Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 145. G7 Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. G7 Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. NATO Tuberculosis Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. NATO Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. NATO Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 150. NATO Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 151. NATO Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 152. NATO Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. NATO Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Global Tuberculosis Test Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. United States Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 156. United States Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. United States Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 158. United States Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 159. United States Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 160. United States Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. United States Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Canada Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 163. Canada Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Canada Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Canada Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 166. Canada Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 167. Canada Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Canada Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Mexico Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 170. Mexico Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. Mexico Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. Mexico Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 173. Mexico Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 174. Mexico Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Mexico Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Brazil Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 177. Brazil Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. Brazil Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. Brazil Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 180. Brazil Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 181. Brazil Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Brazil Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. United Kingdom Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 184. United Kingdom Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. United Kingdom Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 186. United Kingdom Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 187. United Kingdom Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 188. United Kingdom Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. United Kingdom Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Germany Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 191. Germany Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. Germany Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 193. Germany Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 194. Germany Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 195. Germany Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Germany Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. France Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 198. France Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. France Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. France Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 201. France Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 202. France Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. France Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Russia Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 205. Russia Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. Russia Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 207. Russia Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 208. Russia Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 209. Russia Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Russia Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Italy Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 212. Italy Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 213. Italy Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 214. Italy Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 215. Italy Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 216. Italy Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Italy Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Spain Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 219. Spain Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. Spain Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. Spain Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 222. Spain Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 223. Spain Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Spain Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. China Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 226. China Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. China Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. China Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 229. China Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 230. China Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. China Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. India Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 233. India Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. India Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. India Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 236. India Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 237. India Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. India Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. Japan Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 240. Japan Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. Japan Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. Japan Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 243. Japan Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 244. Japan Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Japan Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Australia Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 247. Australia Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. Australia Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. Australia Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 250. Australia Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 251. Australia Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Australia Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. South Korea Tuberculosis Test Kit Market Size, 2017-2032 (USD Million)
TABLE 254. South Korea Tuberculosis Test Kit Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. South Korea Tuberculosis Test Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. South Korea Tuberculosis Test Kit Market Size, by Nucleic Acid Amplification Technology, 2017-2032 (USD Million)
TABLE 257. South Korea Tuberculosis Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 258. South Korea Tuberculosis Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. South Korea Tuberculosis Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Global Tuberculosis Test Kit Market Share, by Key Player, 2025
TABLE 261. Global Tuberculosis Test Kit Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Cepheid, Inc.
  • Eiken Chemical Co., Ltd.
  • F. Hoffmann-La Roche AG (Roche Diagnostics)
  • Hain Lifescience GmbH
  • Hologic, Inc.
  • Molbio Diagnostics Private Limited
  • Oxford Immunotec Ltd.
  • QIAGEN N.V.
  • SD Biosensor, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2026-2032 - Product Image

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Tuberculosis Diagnostics Market - Global Forecast 2026-2032 - Product Image

Tuberculosis Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Mycobacterium Tuberculosis Market Report 2026 - Product Image

Mycobacterium Tuberculosis Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Tuberculosis Diagnostics Market Report 2026 - Product Image

Tuberculosis Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Latent Tuberculosis Infection Detection - Global Strategic Business Report - Product Image

Latent Tuberculosis Infection Detection - Global Strategic Business Report

  • Report
  • 464 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.